Weiyuan Gong
- Rheumatology top 2%
- Osteoarthritis Treatment and Mechanisms 4
- Pharmacology top 10%
- Musculoskeletal pain and rehabilitation 2
-
- Cell Adhesion Molecules Research 4
- Urology top 10%
-
- Spine and Intervertebral Disc Pathology 2
-
- Proteoglycans and glycosaminoglycans research 2
-
- Adenosine and Purinergic Signaling 1
-
- Dialysis and Renal Disease Management 1
-
- Erythropoietin and Anemia Treatment 1
- Journals
- Signal Transduction and Targeted Therapy (1 paper)Frontiers in Endocrinology (1 paper)Aging and Disease (2 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Weiyuan Gong
10 papers receiving 736 citations
Hit Papers
Peers
Comparison fields: 5 of 84
- Rheumatology 456
- Pharmacology 158
- Cancer Research 121
- Immunology and Allergy 37
- Urology 36
Countries citing papers authored by Weiyuan Gong
This map shows the geographic impact of Weiyuan Gong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weiyuan Gong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weiyuan Gong more than expected).
Fields of papers citing papers by Weiyuan Gong
This network shows the impact of papers produced by Weiyuan Gong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weiyuan Gong. The network helps show where Weiyuan Gong may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Weiyuan Gong, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 4 | |
| 2 | 2024 | 1 | |
| 3 | 2023 | 8 | |
| 4 | 2023 | 2 | |
| 5 | 2023 | 6 | |
| 6 | Osteoarthritis: pathogenic signaling pathways and therapeutic targetsbreakdown → | 2023 | 666 |
| 7 | 2022 | 12 | |
| 8 | 2022 | 19 | |
| 9 | 2022 | 7 | |
| 10 | 2021 | 20 |
About Weiyuan Gong
Weiyuan Gong is a scholar working on Immunology and Allergy, Biological Psychiatry and Rheumatology, having authored 10 papers that have together received 745 indexed citations. Recurring topics across this work include Cell Adhesion Molecules Research (4 papers), Osteoarthritis Treatment and Mechanisms (4 papers), Spine and Intervertebral Disc Pathology (2 papers), Proteoglycans and glycosaminoglycans research (2 papers), Musculoskeletal pain and rehabilitation (2 papers), Adenosine and Purinergic Signaling (1 paper), Dialysis and Renal Disease Management (1 paper) and Erythropoietin and Anemia Treatment (1 paper). The work is most often cited by research in Rheumatology (456 citations), Pharmacology (158 citations) and Cancer Research (121 citations). Weiyuan Gong has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Guozhi Xiao, Xiaohao Wu, Minghao Qu, Qing Yao, Chu Tao, Tailin He, Yiming Zhong, Sheng Chen, Yumei Lai and Chunlei Zhou. Their work appears in journals such as Signal Transduction and Targeted Therapy, Frontiers in Endocrinology and Aging and Disease.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.